Tamsulosin to Prevent Postoperative Urinary Retention in Laparoscopic Inguinal Hernia Repair
Stopped early · Phase 4 · Has a placebo group
Conditions studied: Post Operative Urinary Retention
In brief
To investigate the effect of tamsulosin on the development of post-operative urinary retention (PUR) after elective laparoscopic inguinal hernia repair (LIHR). This will be accomplished by administering a pre-operative dose of tamsulosin. The primary outcome is the rate of urinary retention necessitating straight catheterization or insertion of foley catheter prior to discharge.
Key facts
- Study ID
- NCT04434378
- Run by
- Jewish Hospital, Cincinnati, Ohio
- People needed
- 170
- Starts
- 2017-11-16
- Expected to finish
- 2020-02-05
- Last updated by the study team
- 2020-06-16
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- All patients undergoing elective laparoscopic inguinal hernia repair, unilateral or bilateral.
- ≥18 years of age.
- Patients must leave the operating room without at indwelling urinary catheter.
You may not qualify if…
- History of neurogenic bladder requiring routine intermittent catheterization
- Emergent laparoscopic hernia repair.
- Elective laparoscopic hernia repair in conjuncture with an additional operation (e.g. nephrectomy, pelvic surgery) that requires the patient to have a planned, indwelling urinary catheter in the postoperative period.
- Pregnant women.
Where it is running
- Jewish Hospital — Cincinnati, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.